Advertisement

Molecular Medicine

, Volume 10, Issue 1–6, pp 45–54 | Cite as

Reduced Peripheral PGE2 Biosynthesis in Plasmodium falciparum Malaria Occurs through Hemozoin-Induced Suppression of Blood Mononuclear Cell Cyclooxygenase-2 Gene Expression via an Interleukin-10-Independent Mechanism

  • Christopher C. Keller
  • James B. Hittner
  • Benjamin K. Nti
  • J. Brice Weinberg
  • Peter G. Kremsner
  • Douglas J. Perkins
Articles

Abstract

Molecular immunologic determinants of disease severity during Plasmodium falciparum malaria are largely undetermined. Our recent investigations showed that peripheral blood mononuclear cell (PBMC) cyclooxygenase-2 (COX-2) gene expression and plasma prostaglandin E2 (PGE2) production are suppressed in children with falciparum malaria relative to healthy, malaria-exposed children with partial immunity. Furthermore, decreased COX-2/PGE2 levels were significantly associated with increased plasma interleukin-10 (IL-10), an anti-inflammatory cytokine that inhibits the expression of COX-2 gene products. To determine the mechanism(s) responsible for COX-2-derived PGE2 suppression, PBMCs were cultured from children with falciparum malaria. PGE2 production was suppressed under baseline and COX-2-promoting conditions (stimulation with lipopolysaccharide [LPS] and interferon [IFN]-γ) over prolonged periods, suggesting that an in vivo-derived product(s) was responsible for reduced PGE2 biosynthesis. Ingestion of hemozoin (malarial pigment) by PBMC was investigated as a source of COX-2/PGE2 suppression in PBMCs from healthy, malaria-naive adults. In addition, synthetically prepared hemozoin, β-hematin, was used to investigate the effects of the core iron component of hemozoin, ferriprotoporphyrin-IX (FPIX). Physiologic concentrations of hemozoin or β-hematin suppressed LPS- and IFN-γ-induced COX-2 mRNA in a time- and dose-dependent manner, resulting in decreased COX-2 protein and PGE2 production. Suppression of COX-2/PGE2 by hemozoin was not due to decreased cell viability as evidenced by examination of mitochondrial bioactivity. These data illustrate that ingestion of FPIX by blood mononuclear cells is responsible for suppression of COX-2/PGE2. Although hemozoin induced overproduction of IL-10, neutralizing IL-10 antibodies failed to restore PGE2 production. Thus, acquisition of hemozoin by blood mononuclear cells is responsible for suppression of PGE2 in malaria through inhibition of de novo COX-2 transcripts via molecular mechanisms independent of increased IL-10 production.

Notes

Acknowledgments

We thank the staff members of the Albert Schweitzer Hospital in Lambaréné, Gabon, for their cooperation and technical assistance: Anita van den Biggelaar, Judith Jans, Hanna Knoop, Doris Luckner Barbara Moritz, Anselme Ndzengue, Marcel Nkeyi, Daniela Schmid, and Milena Sovric. Furthermore, we would like to thank Dr. Venkatachalam Udhayakumar for his scientific input.

This work was conducted at the University of Pittsburgh and was supported in part by the National Institutes of Health Grants AI-51305-01 (DJP) and AI-41764 (JBW), the VA Research Service (JBW), and the University of Pittsburgh Competitive Research Development Fund (DJP). Portions of this work were presented at The 51st Annual Meeting of the American Society of Tropical Medicine and Hygiene in Denver, CO, in November 2002. The title of the presentation was Cyclooxygenase-2 and Prostaglandin E2 Down-regulation by Hemozoin is Associated with Overproduction of TNF-α Implications for the Pathogenesis of Severe Malaria (abstract number 74).

The study was approved by the ethics committee of the International Foundation of the Albert Schweitzer Hospital, Duke University Medical Center Investigational Review Board, and the University of Pittsburgh Investigational Review Board, and informed consent was obtained from the participants or the parents of participating children.

There is no conflict of interest for any of the authors of the manuscript due to commercial or other affiliations.

References

  1. 1.
    Vane J, Bakhle Y, Botting R. (1998) Cyclooxygenase 1 and 2. Ann. Rev. Pharmacol. Toxicol. 38:97–120.CrossRefGoogle Scholar
  2. 2.
    Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I. (1997) Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17:225–83.CrossRefGoogle Scholar
  3. 3.
    Appleton I, Tomlinson A, Willoughby D. (1996) Induction of cyclooxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:27–78.CrossRefGoogle Scholar
  4. 4.
    Seibert K, Masferrer JL. (1994) Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 4:17–23.PubMedGoogle Scholar
  5. 5.
    Smith WL, Marnett LJ, DeWitt DL. (1991) Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49:153–79.CrossRefGoogle Scholar
  6. 6.
    Perkins DJ, Kremsner PG, Weinberg JB. (2001) Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. J. Infect. Dis. 183:113–8.CrossRefGoogle Scholar
  7. 7.
    Perkins DJ, Hittner JB, Mwaikambo ED, Granger DJ, Weinberg JB, Anstey NM. (2004) Impaired systemic prostaglandin E2 production in children with cerebral malaria. J. Infect. Dis. In press.Google Scholar
  8. 8.
    Francis SE, Sullivan DJ, Jr., Goldberg DE. (1997) Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97–123.CrossRefGoogle Scholar
  9. 9.
    Goldie P, Roth Jr E, Oppenheim J, Vanderberg J. (1990) Biochemical characterization of Plasmodium falciparum hemozoin. Am. J. Trop. Med. Hyg. 43:584–96.CrossRefGoogle Scholar
  10. 10.
    Schwarzer E, Alessio M, Ulliers D, Arese P. (1998) Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect. Immun. 66:1601–6.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Arese P, Schwarzer E. (1997) Malarial pigment (haemozoin): A very active ‘inert’ substance. Ann. Trop. Med. Parasitol. 91:501–16.CrossRefGoogle Scholar
  12. 12.
    Pichyangkul S, Saengkrai P, Webster H. (1994) Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-a and interleukin-1 β. Am. J. Trop. Med. Hyg. 51:430–5.CrossRefGoogle Scholar
  13. 13.
    Mordmuller B, Turrini F, Long H, Kremsner P, Arese P. (1998) Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: Effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production. Eur. Cytokine Netw. 9:2339–246.Google Scholar
  14. 14.
    Perkins DJ, Kniss D. (1997) Tumor necrosis factor-α promotes sustained cyclooxygenase-2 expression: Attenuation by dexamethasone and NSAIDs. Prostaglandins 54:727–43.CrossRefGoogle Scholar
  15. 15.
    Niiro H et al. (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85:3736–45.PubMedGoogle Scholar
  16. 16.
    Schwarzer E, Turrini F, Giribaldi G, Cappadoro M, Arese P. (1993) Phagocytosis of P. falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C. Biochim. Biophys. Acta. 1181:51–4.CrossRefGoogle Scholar
  17. 17.
    Fiori PL et al. (1993) Reduced microbicidal and anti-tumor activities of human monocytes after ingestion of Plasmodium falciparum-infected red blood cells. Parasite Immunol. 15:647–55.CrossRefGoogle Scholar
  18. 18.
    Schwarzer E et al. (1992) Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 176:1033–41.CrossRefGoogle Scholar
  19. 19.
    Keller CC et al. (2004) Elevated nitric oxide production in children with malarial anemia: Hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect. Immun. 72:4868–73.CrossRefGoogle Scholar
  20. 20.
    Kun J et al. (1998) Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans. R. Soc. Trop. Med. Hyg. 92:110–4.CrossRefGoogle Scholar
  21. 21.
    Perkins DJ, Weinberg JB, Kremsner PG. (2000) Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J. Infect. Dis. 182:988–92.CrossRefGoogle Scholar
  22. 22.
    Weinberg JB, Muscato JJ, Niedel JE. (1981) Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. J. Clin. Invest. 68:621–30.CrossRefGoogle Scholar
  23. 23.
    Egan TJ, Mavuso WW, Ncokazi KK. (2001) The mechanism of beta-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes. Biochemistry 40:204–13.CrossRefGoogle Scholar
  24. 24.
    Perkins DJ et al. (2003) In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-a, and IL-10. Biochem. Biophys. Res. Comm. 311:839–46.CrossRefGoogle Scholar
  25. 25.
    Perkins DJ, Kniss DA. (1997) Rapid and transient induction of cyclooxygenase 2 by epidermal growth factor in human amnion-derived WISH cells. Biochem. J. 321:677–81.CrossRefGoogle Scholar
  26. 26.
    Chomczynski P, Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–9.CrossRefGoogle Scholar
  27. 27.
    Sales KJ et al. (2001) Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J. Clin. Endocrinol. Metab. 86:2243–9.CrossRefGoogle Scholar
  28. 28.
    Day NP et al. (1996) Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood 88:4694–700.PubMedGoogle Scholar
  29. 29.
    Olliaro P et al. (2000) Phagocytosis of hemozoin (native and synthetic malaria pigment), and Plasmodium falciparum intraerythrocyte-stage parasites by human and mouse phagocytes. Ultrastruct. Pathol. 24:9–13.CrossRefGoogle Scholar
  30. 30.
    Schwarzer E, Bellomo G, Giribaldi G, Ulliers D, Arese P. (2001) Phagocytosis of malarial pigment haemozoin by human monocytes: a confocal microscopy study. Parasitology 123:125–31.CrossRefGoogle Scholar
  31. 31.
    Slater AF et al. (1991) An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. U.S.A. 88:325–9.CrossRefGoogle Scholar
  32. 32.
    Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. (2000) The structure of malaria pigment beta-haematin. Nature 404:307–10.CrossRefGoogle Scholar
  33. 33.
    Deininger MH, Kremsner PG, Meyermann R, Schluesener HJ. (2000) Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria. J. Neuroimmunol. 106:198–205.CrossRefGoogle Scholar
  34. 34.
    Ball HJ, MacDougall HG, McGregor IS, Hunt NH. (2004) Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J. Infect. Dis. 189:751–8.CrossRefGoogle Scholar
  35. 35.
    Mifflin RC et al. (2002) Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am. J. Physiol. Cell Physiol. 282:C824–34.CrossRefGoogle Scholar
  36. 36.
    Lin CH et al. (2000) Involvement of protein kinase C-gamma in IL-1β-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Mol. Pharmacol. 57:36–43.PubMedGoogle Scholar
  37. 37.
    Dupuis F, Gachard N, Allegraud A, Praloran V, Denizot Y. (1998) Prostaglandin E2 stimulates the growth of human blood CD34+ progenitors. Prostaglandins Other Lipid Mediat. 55:179–86.CrossRefGoogle Scholar
  38. 38.
    Phipps RP, Stein SH, Roper RL. (1991) A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349–52.CrossRefGoogle Scholar
  39. 39.
    Kunkel SL et al. (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380–4.PubMedGoogle Scholar
  40. 40.
    Choi SS, Gatanaga M, Granger GA, Gatanaga T. (1996) Prostaglandin E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cell Immunol. 170:178–84.CrossRefGoogle Scholar
  41. 41.
    Riley EM, MacLennan C, Wiatkowski DK, Greenwood BM. (1989) Suppression of in vitro lymphoproliferative responses in acute malaria patients can be partially reversed by indomethacin. Parasite Immunol. 11:509–17.CrossRefGoogle Scholar
  42. 42.
    Alves MF, Santos-Neto LL, Junqueira MI, Tosta CE, Costa CE. (1992) Cytokines and dysregulation of the immune response in human malaria. Mem. Inst. Oswaldo Cruz 87 Suppl 3:331–6.CrossRefGoogle Scholar
  43. 43.
    Tegeder I, Pfeilschifter J, Geisslinger G. (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15:2057–72.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2004

Authors and Affiliations

  • Christopher C. Keller
    • 1
  • James B. Hittner
    • 2
  • Benjamin K. Nti
    • 1
  • J. Brice Weinberg
    • 3
  • Peter G. Kremsner
    • 4
    • 5
  • Douglas J. Perkins
    • 1
  1. 1.Graduate School of Public Health, Department of Infectious Diseases and MicrobiologyUniversity of PittsburghPittsburghUSA
  2. 2.Department of PsychologyCollege of CharlestonCharlestonUSA
  3. 3.Department of MedicineVA and Duke University Medical CentersDurhamUSA
  4. 4.Medical Research UnitAlbert Schweitzer HospitalLambarénéGabon
  5. 5.Department of Parasitology, Institute for Tropical MedicineUniversity of TübingenTübingenGermany

Personalised recommendations